Toumaz Limited Block Listing Interim Review (4438Z)
18 9월 2015 - 3:00PM
UK Regulatory
TIDMTMZ
RNS Number : 4438Z
Toumaz Limited
18 September 2015
18 September 2015
Toumaz Ltd
Block Listing Interim Review
Pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for
Companies Toumaz Ltd makes the following update on its block
listing:
Name of applicant Toumaz Ltd
-------------------------------------------------- -------------------------------------------
Name of Schemes Block Scheme for
* Toumaz EMI Scheme.
* Toumaz Unapproved Scheme.
* Toumaz Unapproved Scheme 2012.
-------------------------------------------------- -------------------------------------------
Period of return From 19(th) March 2015-18th September
2015.
-------------------------------------------------- -------------------------------------------
Balance of unallotted securities 45,102,979 ORD.25p Shares.
under scheme(s) from previous
return:
-------------------------------------------------- -------------------------------------------
The amount by which the block N/A
scheme(s) has been increased
since the date of the last return
(if any increase has been applied
for):
-------------------------------------------------- -------------------------------------------
Less: Number of securities issued/allotted/Lapsed 572,151 ORD.25p Shares.
under scheme(s) during period.
-------------------------------------------------- -------------------------------------------
Equals: Balance under scheme(s) 44,530,828. ORD 25p Shares.
not yet issued/allotted at end
of period:
-------------------------------------------------- -------------------------------------------
Name of contact Jonathan Apps
----------------------------- ---------------------
Telephone number of contact +44 (0) 20 7391 0630
----------------------------- ---------------------
About Toumaz (www.toumaz.com)
Toumaz Limited is a pioneer in low-power, wireless semiconductor
and software technologies for healthcare and consumer audio. The
company has two divisions, Sensium Healthcare and Frontier Silicon.
Sensium Healthcare develops wireless solutions for patient
monitoring. Frontier Silicon provides chips, modules and software
for digital audio devices.
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRGGUUWBUPAGQM
(END) Dow Jones Newswires
September 18, 2015 02:00 ET (06:00 GMT)
Nanoscience (LSE:NAN)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025
Nanoscience (LSE:NAN)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025
Nanoscience (런던증권거래소)의 실시간 뉴스: 최근 기사 0
More Nanoscience News Articles